Carisma Therapeutics announces board changes By Investing.com

Business News
0
Please log in or register to do it.


Philadelphia-based Carisma Therapeutics Inc. (NASDAQ:CARM), a biopharmaceutical company specializing in pharmaceutical preparations, announced significant changes to its board of directors. On June 26, 2024, board members Regina Hodits, Ph.D., and Björn Odlander, M.D., Ph.D., tendered their resignations effective June 30, 2024.
The departures were attributed to other professional commitments…



Your email address will not be published. Required fields are marked *

Opinion: If you were relieved by the Supreme Court's abortion rulings this term, think again
Live updates: Nation braces for Supreme Court’s Trump immunity decision